Part of the MaRS Best Practices Series. Speaker: Valentia Lee-Brotherton, PhD, Ashuren. This session, led by seasoned industry experts, will explore how to effectively set…
Points to Consider in Preclinical Development Pacific BioLabs, Hercules, CA Presentation Outline Preclinical Development Info & Statistics Reasons For Drug Failure More…
Slide 11 Design of Dose Response Clinical Trials Boston Chapter of ASA April 10, 2006 Naitee Ting, Pfizer Global R&D Slide 2 2 Drug Development Process Drug Discovery…
Slide 1Effectiveness Evaluation for Production Drugs Crystal Groesbeck, Ph.D Division of Production Drugs Slide 2 Articles, other than food, intended to affect the structure…
1. 4/9/[email protected] 2. ICH INTERNATIONAL CONFERENCE ON HARMONIS/ZATION of Technical Requirements for the Registration of Pharmaceuticals for Human4/9/[email protected]…
1. Experiences with Program-level Modeling and Simulation Nitin Patel, Ph.D. Chairman, Co-Founder and CTO Cytel Inc. 2. Disclaimer • The views and opinions expressed…
1. International Guidelines and Regulatory Agencies for Toxicity Studies Supervised by: Dr. Ajay Gaur H.O.D. Quality Assurance Submitted by: Sunil Saini M.Pharm (P`ceutics)…
1. By Dr.Ayshvarya M.D Post-Graduate Guide: Dr Sendhil Kumar Mohan Dr.R.Selvakumar.M.D.D.A.DNB Moderator: Dr.N.Jothi K.A.P.Viswanatham Govt Medical College Trichirapalli…